---
title: "3B Blackbio DX Ltd (532067) — Share Price, Financials & Analysis"
symbol: "532067"
company: "3B Blackbio DX Ltd"
canonical: "https://tapetide.com/stocks/532067"
isin: "INE994E01018"
nse_symbol: "3BBLACKBIO"
bse_code: "532067"
sector: "Healthcare Services"
industry: "Healthcare Service Provider"
market_cap_cr: 1202.43
generated_at: "2026-09-13T18:47:56.623Z"
---

# 3B Blackbio DX Ltd (532067)

Canonical page: https://tapetide.com/stocks/532067

## Company

- **NSE Symbol:** 3BBLACKBIO
- **BSE Code:** 532067
- **ISIN:** INE994E01018
- **Sector:** Healthcare Services
- **Industry:** Healthcare Service Provider
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2026-04-20
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** kilpest.com

## About

Incorporated in 2011, 3B BlackBio Dx Ltd manufactures and exports PCR based Molecular Diagnostic kits, PCR  Enzymes & PCR Reagents, and agrochemical-based products[1]

## Latest Price

- **Price:** ₹1419.9
- **Change:** -23.4 (-1.62%)
- **Open:** ₹1442
- **Day High:** ₹1448.3
- **Day Low:** ₹1389
- **Previous Close:** ₹1443.3
- **Volume:** 19596
- **As Of:** 2026-09-11T09:59:31+00:00

## Key Fundamentals

Observed at 2026-09-11T04:44:40.892009Z.

- **Market Cap:** ₹1202.43 Cr
- **Classification:** Microcap
- **P/E (reported):** 22.1
- **P/E (TTM):** 21.95
- **EPS (TTM):** ₹64.7
- **Book Value:** ₹377.96
- **Price to Book:** 3.83
- **Dividend Yield:** 0.35%
- **ROE:** 17.6%
- **ROCE:** 23.13%
- **Debt to Equity:** 0.01
- **Revenue (yearly):** ₹141.92 Cr
- **Net Income:** ₹60.82 Cr
- **EBITDA:** ₹56.78 Cr
- **52-Week High:** ₹1588.9
- **52-Week Low:** ₹1085
- **RSI (14):** 59.6

## Tapetide Score

- **Score:** 67 / 100
- **Score date:** 2026-09-04
- **Archetype:** Quality at a Reasonable Price
- **What it means:** Financial strength is not being paid for with a demanding multiple. The question worth asking is whether the quality is durable or reflects a good patch — check the consistency of returns over several years rather than the latest quarter.
- **Pillar profile:** Quality: Good · Valuation: Cheap · Momentum: Flat
- **Percentile:** 98.2 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 90.68 | 9% |
| growth | 98.9 | 9% |
| momentum | 50.2 | 12% |
| ownership | 52.91 | 24% |
| quality | 74.71 | 22% |
| valuation | 65.92 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company is expected to give good quarter
- Company's median sales growth is 21.9% of last 10 years

### Weaknesses

- Earnings include an other income of Rs.27.4 Cr.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 60.89% | 113.81% | -55.54% |
| ebitda margin growth | -20.97% | -41.99% | -35.45% | -32.55% |
| net income growth | -8.16% | 27.51% | 31% | -12% |
| revenue growth | -13.16% | 27.17% | 32% | -9% |
| roce | -9.69% | 19.97% | 30.16% | 37.21% |
| roe | -8.37% | 23.6% | 15.03% | -77.08% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 19.18 | 17.67 | 23 | 19.43 | 29.15 | 25.39 | 22.5 | 22.23 | 33.9 | 50.35 | 35.43 | 33.49 |
| Expenses | 11.39 | 8.8 | 13.12 | 8.48 | 12.98 | 10.32 | 14.58 | 10.4 | 19.17 | 28.63 | 26.94 | 24.97 |
| Operating Profit | 7.79 | 8.87 | 9.88 | 10.95 | 16.17 | 15.07 | 7.92 | 11.83 | 14.73 | 21.72 | 8.49 | 8.52 |
| OPM % | 40.62 | 50.2 | 42.96 | 56.36 | 55.47 | 59.35 | 35.2 | 53.22 | 43.45 | 43.14 | 23.96 | 25.44 |
| Other Income | 2.75 | 2.63 | 4.19 | 3.69 | 3.44 | 3.01 | 4.94 | 4.32 | 5.51 | 5.59 | 10.15 | 6.14 |
| Interest | 0.04 | 0.03 | 0.04 | 0.01 | 0.03 | 0.02 | 0.04 | 0.01 | 0.04 | 0.09 | 0.1 | 0.1 |
| Depreciation | 0.24 | 0.32 | 0.3 | 0.27 | 0.27 | 0.27 | 0.28 | 0.28 | 0.58 | 0.38 | 3.89 | 1.34 |
| Profit before tax | 10.26 | 11.15 | 13.73 | 14.36 | 19.31 | 17.79 | 12.54 | 15.86 | 19.62 | 26.84 | 14.65 | 13.22 |
| Tax % | 26.02 | 23.68 | 35.98 | 21.31 | 22.99 | 24.17 | 35.89 | 20.3 | 23.34 | 16.39 | 33.11 | 32.07 |
| Net Profit | 7.58 | 8.51 | 8.79 | 11.3 | 14.87 | 13.49 | 8.04 | 12.65 | 15.04 | 22.44 | 9.81 | 8.98 |
| EPS in Rs | 10.46 | 10.16 | 10.33 | 12.97 | 17.07 | 15.61 | 9.79 | 14.67 | 17.14 | 25.32 | 11.14 | 11.1 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 23 | 23 | 29 | 227 | 81 | 62 | 74 | 96 | 142 | 153 |
| Expenses | 18 | 16 | 20 | 77 | 44 | 33 | 41 | 46 | 85 | 100 |
| Operating Profit | 5 | 7 | 9 | 150 | 37 | 29 | 33 | 50 | 57 | 53 |
| OPM % | 23 | 31 | 32 | 66 | 46 | 47 | 44 | 52 | 40 | 35 |
| Other Income | 0 | 1 | 2 | 3 | 7 | 7 | 13 | 15 | 26 | 27 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 6 |
| Profit before tax | 5 | 7 | 10 | 152 | 43 | 35 | 44 | 64 | 77 | 74 |
| Tax % | 24 | 25 | 23 | 25 | 26 | 27 | 28 | 25 | 22 | — |
| Net Profit | 3 | 5 | 8 | 114 | 32 | 26 | 32 | 48 | 60 | 56 |
| EPS in Rs | 5.35 | 8.18 | 10.24 | 151.66 | 42.89 | 34.55 | 37.4 | 55.57 | 68.27 | 64.7 |
| Dividend Payout % | 9 | 6 | 7 | 6 | 24 | 8 | 8 | 7 | 7 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 6 | 6 | 6 | 7 | 7 | 7 | 9 | 9 | 9 | 9 |
| Reserves | 5 | 12 | 16 | 25 | 125 | 146 | 185 | 214 | 260 | 316 |
| Borrowings | 9 | 6 | 6 | 4 | 2 | 3 | 2 | 1 | 0 | 3 |
| Other Liabilities | 6 | 6 | 8 | 9 | 59 | 37 | 19 | 24 | 27 | 51 |
| Total Liabilities | 26 | 30 | 36 | 45 | 194 | 192 | 214 | 248 | 296 | 378 |
| Fixed Assets | 3 | 4 | 4 | 4 | 5 | 7 | 8 | 7 | 7 | 28 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 1 | 59 | 93 | 92 | 117 | 156 | 158 |
| Other Assets | 22 | 26 | 32 | 40 | 130 | 93 | 114 | 123 | 132 | 193 |
| Total Assets | 26 | 30 | 36 | 45 | 194 | 192 | 214 | 248 | 296 | 378 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 1 | 2 | 4 | 7 | 98 | 37 | 20 | 27 | 43 | 52 |
| Cash from Investing Activity | 0 | -1 | -1 | -1 | -70 | -28 | 15 | -20 | -33 | -24 |
| Cash from Financing Activity | 0 | 0 | -1 | 1 | -2 | -15 | -5 | -4 | -3 | -1 |
| Net Cash Flow | 0 | 1 | 2 | 7 | 26 | -6 | 30 | 3 | 7 | 28 |
| Free Cash Flow | 0 | 1 | 3 | 6 | 96 | 35 | 18 | 26 | 42 | 27 |
| CFO/OP | 36 | 52 | 71 | 101 | 90 | 129 | 100 | 115 | 116 | 121 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 321 | 259 | 290 | 252 | 56 | 136 | 200 | 179 | 138 | 129 |
| Inventory Days | 175 | — | — | — | — | — | 164 | 141 | 124 | 187 |
| Days Payable | 186 | — | — | — | — | — | 69 | 66 | 28 | 70 |
| Cash Conversion Cycle | 310 | 259 | 290 | 252 | 56 | 136 | 296 | 253 | 235 | 245 |
| Working Capital Days | 247 | 253 | 287 | 275 | 65 | 162 | 241 | 215 | 169 | 143 |
| ROCE % | 13 | 24 | 28 | 31 | 162 | 27 | 19 | 21 | 26 | 25 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 38.43% | 38.43% | 41.29% | 41.29% | 41.29% | 41.29% | 41.28% | 41.28% | 41.28% | 41.28% | 40.94% | 40.95% |
| FIIs | 3.16% | 3.38% | 2.97% | 3.28% | 3.27% | 2.68% | 2.49% | 2.7% | 2.64% | 2.57% | 2.57% | 2.5% |
| DIIs | 0% | 1.18% | 1.89% | 1.96% | 1.96% | 1.74% | 1.6% | 1.76% | 1.82% | 1.88% | 1.98% | 2.15% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 43.38% | 43.01% | 41.94% | 42.22% | 42.41% | 42.8% | 43.31% | 43.17% | 43.53% | 38.09% | 37.73% | 37.05% |
| Others | 15.03% | 13.99% | 11.92% | 11.26% | 11.07% | 11.49% | 11.32% | 11.09% | 10.73% | 16.19% | 16.78% | 17.35% |
| No. of Shareholders | 10513 | 10088 | 9753 | 9399 | 9586 | 10166 | 10345 | 10619 | 10709 | 10507 | 10616 | 11049 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 12 / 5 / 2

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1471.21 | Sell |
| EMA (10) | 1437.39 | Sell |
| SMA (20) | 1356.4 | Buy |
| EMA (20) | 1388.38 | Buy |
| SMA (50) | 1282.47 | Buy |
| EMA (50) | 1314.86 | Buy |
| SMA (100) | 1257.63 | Buy |
| EMA (100) | 1295.57 | Buy |
| SMA (200) | 1329.02 | Buy |
| EMA (200) | 1339.35 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 56.63 | Neutral |
| MACD (12,26,9) | 61.96 | Buy |
| Stochastic (14,3,3) | 63.9 | Neutral |
| ADX (14) | 27.98 | Buy |
| Williams %R (14) | -47.1 | Neutral |
| ATR (14) | 72.81 | High Volatility |
| ROC (12) | 8.7 | Buy |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 42.46 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9m - Virtual institutional investor meeting on 11 March 2026 at 5:00 PM, organized by Arihant Capital (group). | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 9m - Virtual institutional investor meeting on 11 March 2026 at 5:00 PM, organized by Arihant Capital (group).](https://www.bseindia.com/xml-data/corpfiling/AttachLive/b3e9f2a6-9009-4144-a6ff-621b051a89f3.pdf) |
| 9h - Board meeting March 12 to consider loan and conversion to equity for Melt 'N' Mellow; postal ballot, e-voting. | [Board Meeting Intimation for The Meeting Of Board Of The Company Is Scheduled To Be Held On Thursday, March 12, 2026 9h - Board meeting March 12 to consider loan and conversion to equity for Melt 'N' Mellow; postal ballot, e-voting.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/dd631c7d-4b1c-4bdb-b243-14f40fa3b5d9.pdf) |
| 7 Feb - Submission of Advertisement Clipping of the extract of the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 7 Feb - Submission of Advertisement Clipping of the extract of the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/baa9dda1-8d92-43fe-a8fb-7a45c6007637.pdf) |
| 6 Feb - Earning Concall under Regulation 30 of the SEBI (LODR) Regulations. 2015. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 6 Feb - Earning Concall under Regulation 30 of the SEBI (LODR) Regulations. 2015.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7ef527fe-c629-4e50-a01f-0587b83335ac.pdf) |
| 6 Feb - Approved unaudited Q3 and 9M results to Dec 31, 2025; consolidated 9M PAT Rs4,903.08 lakh. | [Board Meeting Outcome for Outcome Of Board Meeting 6 Feb - Approved unaudited Q3 and 9M results to Dec 31, 2025; consolidated 9M PAT Rs4,903.08 lakh.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/77b85e1a-be59-4ee9-ae94-e09b087a9a25.pdf) |
| 4 Apr - Promoter disclosed no share encumbrance or pledge during FY ended March 31, 2026. | [Disclosure Under Regulation 31(4) Of SEBI (SAST) Regulations, 2011 4 Apr - Promoter disclosed no share encumbrance or pledge during FY ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a79286a7-0e9f-45a3-b758-102a09f54e8b.pdf) |
| 4 Apr - Newspaper Publication regarding Second "100 Days Campaign - Saksham Niveshak" | [Announcement under Regulation 30 (LODR)-Newspaper Publication 4 Apr - Newspaper Publication regarding Second "100 Days Campaign - Saksham Niveshak"](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3023fa35-5f0f-4683-a5b0-f5ea4f25cce1.pdf) |
| 30 Jan - Board meeting Feb 10, 2026 to approve Q3 (Dec 31, 2025) unaudited results and ESOP grant. | [Board Meeting Intimation for Intimation Of Board Meeting 30 Jan - Board meeting Feb 10, 2026 to approve Q3 (Dec 31, 2025) unaudited results and ESOP grant.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/66ffdb0e-49fa-489c-80a8-b004927bc50e.pdf) |
| 26 Mar - Trading window closed from 1 April 2026 until 48 hours after FY2026 audited results submission. | [Closure of Trading Window 26 Mar - Trading window closed from 1 April 2026 until 48 hours after FY2026 audited results submission.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0298410d-a69b-43c0-af27-6098ca3002ef.pdf) |
| 24 Feb - Transcript of Q3/9M FY26 results; Coris Q3 revenue INR24 crore, HAT one-off ~INR8.8 crore; growth guidance 10–15%. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 24 Feb - Transcript of Q3/9M FY26 results; Coris Q3 revenue INR24 crore, HAT one-off ~INR8.8 crore; growth guidance 10–15%.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0922218a-578c-4405-b962-c9b594990461.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-08 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec90217f-bda8-4c51-892b-f7cacab9f664.pdf) |
| 2026-09-07 | [Annual General Meeting To Be Held On 29Th September 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b44bc43-09e9-48c6-8761-68fb5b5341b4.pdf) |
| 2026-09-07 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18ca61c4-c0e5-4551-b4ad-978adc06d550.pdf) |
| 2026-09-07 | [Record Date And Date Of Book Closure For The Purpose Of Dividend And AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0499e7db-f935-4bde-9357-b69ffe0f898f.pdf) |
| 2026-09-07 | [Dividend Updates](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d1b05f1-c18f-45a1-8dfd-b3f63feff431.pdf) |
| 2026-09-07 | [Annual General Meeting To Be Held On 29Th September 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a7068ef-ff33-46aa-a42d-b82f6416a3e1.pdf) |
| 2026-09-07 | [Letter To Shareholders](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01634894-ab0c-4b47-95fa-57e600aedd99.pdf) |
| 2026-09-05 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11442498-1f7e-4ebe-9a51-fd990d73c5d4.pdf) |
| 2026-09-05 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f52a2b02-d6d8-47df-bf28-7d21ef73268d.pdf) |
| 2026-08-29 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f8a615e-bba3-48b1-98eb-377f4027efb5.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-13 | [Unaudited Financial Results For The Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a471082-4786-47a9-804d-9cd82b4f285f.pdf) |
| 2026-05-29 | [Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended On 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73b3391c-d70c-40e6-9cb9-3b6ce629af30.pdf) |
| 2026-02-06 | [Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb5fd945-847e-44d7-8152-ceb5c87127fa.pdf) |
| 2025-11-13 | [Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30Th September2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07447efd-ea40-4f7a-bfc9-827e9e4b446e.pdf) |
| 2025-08-14 | [Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended On 30Th June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f289bf45-a0a1-4521-a66b-7d8072a7dac7.pdf) |
| 2025-06-14 | [Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended 31-03-2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f28c07a6-679f-48ae-9c47-7c05ad75ac6c.pdf) |
| 2025-02-13 | [Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine-Months Ended 31-12-2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=abaca334-4ed5-486e-b9fb-a30b10d79098.pdf) |
| 2024-11-13 | [Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41190ab8-45df-452c-ae82-858b94f938e0.pdf) |
| 2024-08-12 | [Unaudited Standalone And Consolidated Financial Results For Quarter Ended 30-06-24](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=60c7346c-7a1b-48b1-89c9-e6cc582b9364.pdf) |
| 2024-05-29 | [Submission Of Audited Financial Results Of The Company For The Quarter And Financial Year Ended 31 March, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=707268e4-203f-4e58-81e0-f5669ab05225.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a22f42e-44dd-46cb-806e-7d2b58d2fab1.pdf) |
| 2026-05-29 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=810ea61b-eb09-4934-a87b-d774761fdee1.pdf) |
| 2026-02-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a4a4f54-fda7-4347-a389-476078da79a2.pdf) |
| 2025-11-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=351b9755-ddaf-4a3c-967e-07f8f28e5338.pdf) |
| 2025-08-14 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f759a690-33a5-43d6-b8f9-e931e53073fa.pdf) |
| 2025-05-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba4117d1-ce71-45de-af59-2295a2552e07.pdf) |
| 2024-11-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6fa9eb9e-335b-4818-8cfe-893e3a0c2c9c.pdf) |
| 2024-08-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc7df726-c8be-4989-bc5f-f52b4953c905.pdf) |
| 2023-11-10 | [Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30Th September, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55d3303e-27c1-431f-b8f4-b16113314fbd.pdf) |
| 2023-08-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76c4d87d-d4f4-43f5-9079-e6ffa749e195.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2022 | [Concall - Sep 2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c4a0b147-b0a1-41fb-9103-15ad0e088e61.pdf) |
| Sep 2022 | [Concall - Sep 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c4a0b147-b0a1-41fb-9103-15ad0e088e61.pdf) |
| Sep 2021 | [Concall - Sep 2021](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ed71e64-0c28-4af2-991d-2dce4ed2049b.pdf) |
| Sep 2021 | [Concall - Sep 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3ed71e64-0c28-4af2-991d-2dce4ed2049b.pdf) |
| Sep 2020 | [Concall - Sep 2020](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ac82717-ceef-4531-b5b1-d30d98379738.pdf) |
| Sep 2020 | [Concall - Sep 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2ac82717-ceef-4531-b5b1-d30d98379738.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e53c1fa5-4eaf-4553-a985-c89a2bc165eb.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/351b9755-ddaf-4a3c-967e-07f8f28e5338.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6fa9eb9e-335b-4818-8cfe-893e3a0c2c9c.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/55d3303e-27c1-431f-b8f4-b16113314fbd.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-06-01 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5dc06bd-60b7-4d0a-aaf1-30d918f747c9.pdf) |
| 2026-02-21 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa724cfe-5ee3-4cf0-9b13-06a82e585c26.pdf) |
| 2025-08-19 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fefce302-ff5e-40f8-a4d7-aa5f8feefe2d.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_24974_KRISHIVAL_2023_2024_16082024181221.pdf) |
| from nse | [Financial Year 2023 from nse](https://archives.nseindia.com/annual_reports/SME_AR_22065_KRISHIVAL_2022_2023_24062023165306_06242023170000.zip) |
| from nse | [Financial Year 2022 from nse](https://archives.nseindia.com/annual_reports/SME_AR_19973_KRISHIVAL_2021_2022_02062022094828_06022022100002.zip) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e37aa8df-e5c3-4185-8528-760d8fcfafcc.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a8b077cc-8988-4e83-8ede-ed5708613933.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d8623fdb-2310-4648-b3aa-88daec83ac42.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3cd5d62d-271e-45af-a668-2d4698e4575e.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/532067/74804532067.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/532067/70106532067.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/532067/65557532067.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:47:56.623Z.